Overview of Sales, Earnings and Financial Position
Kogenate®
Bayer Links
News
Further E.U. approval for Kogenate® Bayer
Leverkusen. The European Commission has granted Bayer HealthCare (BHC) a further approval for Kogenate® Bayer, which can now also be used for continuous infusion in hemophilia A patients undergoing major surgery. BHC is the first manufacturer to be granted the continuous infusion indication by the European Commission for all E.U. countries. This product provides surgeons with increased confidence in treating hemophilia patients.
Bookmark this page
E-mail this page
Advanced Search
